Abstract:Background . The prognosis of patients with hepatocellular carcinoma (HCC) is poor, with 60% to 70% of patients developing recurrence and metastasis within five years of radical resection. Alpha-fetoprotein (AFP) plays a significant role in predicting the recurrence and metastasis of HCC after surgery. However, its role in modulating tumor immunity has not been investigated. Our objective was to examine the effect of AFP on the expression of B7 family and activation of the NF- κ B (P65) pathway in HCC. Methods . We generated human hepatoma SMMC-7721 cell lines with or without recombinant AFP transfection (AFPup and control groups). Colony formation assay, Transwell invasion assay, and wound healing assay were used to detect the function of AFP. Liver cancer xenografts were made in BALB/c nude male mice ( N = 6 per group). After 28 days of inoculation, the expression of immune genes in the HCC tissues, including PD-L (B7-H1), B7-H3, B7-H4, and P65, was evaluated by quantitative real-time PCR (qPCR) and western blot. In addition, immunofluorescence was used to determine the subcellular localization of the P65 protein, a key factor in the NF- κ B pathway. An online HCC patients’ dataset was also used to detect the connection between AFP and P65. Results . Overexpression of AFP could enhance proliferation, invasion, and migration of HCC cells. Both qPCR and western blot results demonstrated that the expressions of PD-L1, B7-H4, and P65 were significantly higher in the AFP group compared to the controls ( P < 0.05 ). Immunofluorescence results indicated that the majority of the P65 protein was located in the cytoplasm in the control group but was translocated to the nucleus in the AFPup group. The Spearman correlation coefficient confirms that AFP has a positive correlation with P65 in HCC patients ( R = 0.33, P = 0.05 ). Conclusion . AFP could enhance proliferation, invasion, and migration in HCC cells. The upregulation of AFP would increase the PD-L1 and B7-H4 mRNA and protein expression in HCC tissues through the upregulation and activation of the P65 protein.

Alpha-Fetoprotein Triggers Hepatoma Cells Escaping from Immune Surveillance Through Altering the Expression of Fas/Fasl and Tumor Necrosis Factor Related Apoptosis-Inducing Ligand and Its Receptor of Lymphocytes and Liver Cancer Cells

Effects of Alpha Fetoprotein on Escape of Bel 7402 Cells from Attack of Lymphocytes

[Effects of alpha-fetoprotein on the expression of TRAIL death receptor-2 and its role on resisting the cytotoxicity of TRAIL in hepatoma cells]

α-Fetoprotein shields hepatocellular carcinoma cells from apoptosis induced by tumor necrosis factor-related apoptosis-inducing ligand

Alpha Fetoprotein Is A Novel Protein-Binding Partner For Caspase-3 And Blocks The Apoptotic Signaling Pathway In Human Hepatoma Cells

Alpha-Fetoprotein Regulates the Expression of Immune-Related Proteins through the NF- κ B (P65) Pathway in Hepatocellular Carcinoma Cells

Alpha-fetoprotein Stimulated the Expression of Some Oncogenes in Human Hepatocellular Carcinoma Bel 7402 Cells.

Silencing Alpha-Fetoprotein Inhibits VEGF and MMP-2/9 Production in Human Hepatocellular Carcinoma Cell.

Alpha-fetoprotein accelerates the progression of hepatocellular carcinoma by promoting Bcl-2 gene expression through an RA-RAR signalling pathway

Early Alpha-Fetoprotein Response Predicts Treatment Efficacy of Antiangiogenic Systemic Therapy in Patients with Advanced Hepatocellular Carcinoma.

Elevated Serum Alpha Fetoprotein Levels Promote Pathological Progression of Hepatocellular Carcinoma

Effects of alpha-fetoprotein on the occurrence and progression of hepatocellular carcinoma

Alpha-fetoprotein Acts As a Novel Signal Molecule and Mediates Transcription of Fn14 in Human Hepatocellular Carcinoma

A novel anti-alpha-fetoprotein single-chain variable fragment displays anti-tumor effects in HepG2 cells as a single agent or in combination with paclitaxel

Identification of α-fetoprotein-specific T cell receptors for hepatocellular carcinoma immunotherapy.

Tuning T‐Cell Receptor Affinity to Optimize Clinical Risk‐Benefit When Targeting Alpha‐Fetoprotein–Positive Liver Cancer

Alpha-Fetoprotein: A New Member of Intracellular Signal Molecules in Regulation of the Pi3k/Akt Signaling in Human Hepatoma Cell Lines

[Quantitation of Alpha-Fetoprotein Messenger RNA in Peripheral Blood of Nude Mice and Its Relationship with Tumor Recurrence and Metastasis after Curative Resection of Hepatocellular Carcinoma].

Early Alpha‐foetoprotein Response Associated with Treatment Efficacy of Immune Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma

Induction of Α-Fetoprotein-specific CD4- and CD8-mediated T-cell Response Using RNA-transfected Dendritic Cells

Role of Alpha-Fetoprotein in Hepatocellular Carcinoma Drug Resistance